Semaglutide

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist consisting of 31 amino acids, structurally modified from native GLP-1 to extend its half-life through albumin binding. It has been the subject of extensive preclinical and clinical research, representing one of the most comprehensively studied peptide compounds in the modern pharmacological literature.

Researchers have investigated Semaglutide across a broad range of in vitro and in vivo models, with an extensive body of published clinical trial data examining its interactions with GLP-1 receptors in pancreatic beta cells and its role in glycaemic regulation and type 2 diabetes management. Published research has further examined Semaglutide in models relating to body weight modulation, cardiovascular outcomes, non-alcoholic fatty liver disease, neuroinflammation, and most recently, neurodegenerative disease pathways including Alzheimer’s disease.

Ambros Labs supplies Semaglutide to qualified researchers across Canada from our Canadian inventory. Every batch is independently tested by a third-party Canadian laboratory using HPLC and mass spectrometry, with verifiable Certificates of Analysis available for every batch. All orders ship same-day from Canada with full chain of custody documentation.

For research use only. Not for human or veterinary use. For use by qualified researchers in appropriate laboratory settings only.

CAS Number: 910463-68-2

Molecular Weight (g/moL): 4113.64

Molecular Formula: C187H291N45O59

Sequence: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH

Format: White Lyophilized Powder

Database Link